According to several studies on cancer cells, it was concluded that PKC not only activates NF-κB by inhibiting IκBα in the cytoplasm to prevent translocation into the nucleus, but also regulates Rho A signaling to stimulate EMT [54,55,56,57]. Here, PRRT2 is linked to cancer.